The European Union approved a new vaccine to prevent Ebola virus disease (Zaire ebolavirus species) in individuals aged 1 year and older. The vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.
A new Canadian Government study showed a 59.1% increase in MRSA bloodstream infections (0.66 to 1.05 infections per 10,000 patient-days) and a 143% increase in VRE bloodstream infections (0.14 to 0.34 infections per 10,000 patient-days).
Eli Liily has started a randomized, placebo-controlled, double-blind Phase 1 trial that aims to investigate the safety, tolerability, and efficacy of their COVID-19 Antibody experimental drug (LY-CoV555). The trial will administer a single dose of the drug administered to participants hospitalized for COVID-19. This drug is the first potential new medicine specifically designed to attack SARS-CoV-2, the virus that causes COVID-19.
Johns Hopkins Bloomberg School of Public Health issued a report on Gene Drives which makes recommendations for the responsible governance of gene drives as a used and normalized tool.
The United States Department of Homeland Security developed a tool for calculating the decay of SARS CoV-2 on surfaces. The calculator can be assessed via the link.
The World Health Organization (WHO) released its Weekly Bulletin on Outbreaks in Africa. The Democratic Republic of Congo (DRC) is being closely monitored since its resurgence of Ebola in Beni on 10 April 2020. The outbreak has gone 27 days without a new case, but the WHO has identified one new probable case of EVD was retrospectively validated in Mabalako, increasing the overall case-count by one. This case was believed to be infected on 22 May 2020. The COVID-19 outbreak continues to expand in Africa. The cumulative case count surpasses 100 000, with an average of 2 000 cases reporte
Between 2 and 8 April 2020, six suspected human cases of dracunculiasis in Duli village, Gog district, Gambella region, Ethiopia, were reported to WHO.
The U.S. Food and Drug Administration published the findings of an investigation into the contamination of romaine lettuce implicated in three outbreaks of E. coli O157:H7 during the Fall of 2019. These findings, together with the findings from earlier leafy greens outbreaks dating back to 2013, suggest that a potential contributing factor has been the proximity of cattle—a persistent source of E. coli O157:H7 and other STEC—to the produce fields identified in traceback investigations.
Artificial Intelligence (AI) has the potential to speed up the time to bring a vaccine to market by accelerating the process of human trials.
This study found that simulated sunlight rapidly inactivated SARS-CoV-2 suspended in either simulated saliva or culture media and dried on stainless steel coupons.